Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer
- Conditions
- Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage IB Breast CancerStage IIIA Breast CancerStage IIIC Breast CancerStage IA Breast CancerRecurrent Breast CancerStage II Breast CancerStage IIIB Breast CancerStage IV Breast Cancer
- Interventions
- Procedure: breast reconstructionProcedure: intraoperative imaging
- Registration Number
- NCT01729832
- Brief Summary
Many hospitals, including the Ohio State University Medical Center, will take pictures of the blood vessels in a patient's abdomen before they decide to perform a breast reconstruction using the patient's own tissue. These pictures are called computed tomography (CT) angiograms and are like a map of each patient's anatomy. However, no study has been reported that determined how accurate these pictures are at showing the surgeon where all of the blood vessels were located. This study will try to determine if these pictures are missing any blood vessels that are found during surgery and if the pictures show the correct location of the vessels
- Detailed Description
PRIMARY OBJECTIVES:
I. To analyze the accuracy of preoperative CT angiography in determining the location of perforator vessels. Through the use of an intraoperative navigation system, we will objectively locate perforators during surgery and compare the results to the preoperative imaging assessment of the flap's vascular anatomy.
II. To determine whether the preoperative CT angiogram allows the microsurgeon to correctly identify the perforators that are ultimately used as the pedicle for the flap.
OUTLINE:
Patients undergo deep inferior epigastric perforator (DIEP) flap breast reconstruction using the StealthStation navigation system.
After completion of study treatment, patients are followed up at 1-2 weeks and 1 month, then every 3 months for 2 years.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- Patients with histologically confirmed breast carcinoma or breast carcinoma in situ desiring unilateral or bilateral deep inferior epigastric perforator (DIEP) flap breast reconstruction
- Patients must be candidates for elective surgery, without clinically significant cardiac or pulmonary disease (New York Heart Association [NYHA] class III/IV), without infection requiring antibiotics, and without serious illness requiring the use of steroids
- Patients must have normal kidney function and no allergy to intravenous (IV) dye
- Patients with previous abdominal donor site flaps will be excluded along with patients with previous extensive surgery to the anterior abdomen
- Patients with a weight of over 300 pounds or a body size not supported by the CT scanner will be excluded
- Patients who are expected to undergo postoperative radiation therapy will be excluded
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Supportive care (image-guided breast reconstruction) breast reconstruction Patients undergo DIEP flap breast reconstruction using the StealthStation navigation system. Supportive care (image-guided breast reconstruction) intraoperative imaging Patients undergo DIEP flap breast reconstruction using the StealthStation navigation system.
- Primary Outcome Measures
Name Time Method Whether the preoperative CT angiography allowed the surgeon to accurately predict the perforator vessels that were actually used in the final flap design and transfer Up to 2 years The number of perforators that are found intraoperatively but not seen preoperatively on CT angiogram images Up to 2 years
- Secondary Outcome Measures
Name Time Method Position of the vessels on the imaging correlate to actual location on the abdominal wall for those perforator vessels that are identified both on preoperative review of the images and located during flap dissection Up to 2 years